KP Tissue Inc's stock has seen modest fluctuations this week, reflecting broader market sentiments and company-specific developments.
KP Tissue Inc (KPT.TO) closed at C$13.04, marking a slight increase of 0.54% on Wednesday. Despite this daily gain, the stock has experienced a minor decline of 0.53% over the past week. Year-to-date, however, KP Tissue has performed well, showing an impressive increase of 27.89%.
Advertisement
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$129.36M
P/E
14.3x
Div. yield
5.56%
Div. / share
$0.72
52W high
$13.61
52W low
$8.68
1W change
-0.93%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to rise 0.6% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.88
+0.6% Upside
Current Price
C$12.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
15.6%
Annualized
90-Day Vol
16.1%
Annualized
Trend (90d)
+48.6%
Annualized drift
90d Mean
C$15.23
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.56 | C$12.85 – C$14.31 |
| 60 trading days | C$14.37 | C$13.32 – C$15.51 |
| 90 trading days | C$15.23 | C$13.87 – C$16.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may want to keep an eye on KP Tissue's upcoming announcements and financial performance, particularly in light of recent developments regarding dividends and shareholder meetings.
KP Tissue Inc's Stock Shows Stability with a YTD Gain of 27.89%
The stock's performance reflects a solid trend in the consumer staples sector, with KP Tissue managing to maintain a price well above its 200-day moving average.
Bull case
The recent declaration of a quarterly dividend and strong financial results could boost investor confidence. This might attract more buyers in the consumer staples sector.
Bear case
Even with positive financial indicators, the company's profit margin remains at 0.0%. This raises concerns about its long-term profitability and growth potential.
Recent Price Action
Advertisement
KP Tissue Inc's stock closed at C$13.04 on Wednesday, reflecting a daily gain of 0.54%. However, over the past week, the stock has seen a slight decline of 0.53%. Year-to-date, KP Tissue has shown a robust performance, with a notable increase of 27.89%, indicating positive momentum in a challenging market.
Company Developments
While there were no major announcements this week, recent headlines include KP Tissue's declaration of a quarterly dividend of $0.21 per share and the release of its first-quarter financial results for 2026, showcasing strong profitability with an adjusted EBITDA increase of 14.6% year-over-year. These developments may have implications for investor sentiment moving forward.
Technical Picture
From a technical perspective, KP Tissue's stock is currently trading above its 50-day moving average of C$12.51, representing a 4.2% premium. The stock is also well above its 200-day moving average of C$10.86, indicating a strong upward trend. The 52-week range for KP Tissue is between C$8.20 and C$13.61, which means the stock is currently trading at 89% of its 52-week high. With a beta of 0.40, the stock exhibits lower volatility compared to the broader market.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
